BBIO: BridgeBio Pharma, Inc. Common Stock Company Profile & Statistics

About

BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.

Info & Links

CEO

Neil Kumar

Headquarters

3160 PORTER DR., SUITE 250
PALO ALTO, CA 94304, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

730

BridgeBio Pharma, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

6.93B

Enterprise Value

7.97B

Enterprise Value/EBITDA(ttm)

-13.59

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

31.35

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

78.99%

Operating Margin(ttm)

-275.28%

Profit Margin(ttm)

-4743.01%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-94.43%

Return on Assets(ttm)

-79.38%

Income Statement

Revenue(ttm)

221.90M

Revenue Per Share(ttm)

1.17

Gross Profit(ttm)

218.02M

EBITDA(ttm)³

-586.90M

Net Income Available to Common(ttm)

-535.76M

Diluted EPS(ttm)

-2.85

Share Statistics

Beta (5Y Monthly)

1.07

52-Week Change

7.74%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

190.19M

Dividend Yield

0.00%

Float⁴

142.38M

% Held by Insiders

24.66%

% Held by Institutions

99.85%

Balance Sheet

Total Cash(mrq)

681.23M

Total Cash Per Share(mrq)

3.58

Total Debt(mrq)

1.72B

Total Debt/Equity(mrq)

-141.04%

Current Ratio(mrq)

3.19%

Quick Ratio(mrq)

3.19%

Book Value Per Share(mrq)

-6.45

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.73

Free Cash Flow(ytd)

-326.29M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BBIO

BridgeBio Pharma, Inc. Common Stock

BridgeBio Pharma, Inc. Common Stock Profile